Status:
UNKNOWN
Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Cancer
Venous Thromboembolism
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective study with the following objectives: Primary Objective: 1. To estimate the prevalence of unsuspected VTE in oncology patients on routine staging CT scans of the thorax, abdomen...
Detailed Description
Patients diagnosed with cancer are routinely scheduled for staging CT scans. The CT scans are obtained to stage a new cancer diagnosis, to restage a cancer after treatment initiation or to evaluate ab...
Eligibility Criteria
Inclusion
- Patients with a diagnosis of cancer.
- Subjects must be 18 years or more.
- Male and female patients are eligible for enrollment.
- Patients who are scheduled for routine outpatient cancer staging using CT scans.
- Patients must be able to complete the required survey tools independently.
- Patients must be able to speak, read and write English.
Exclusion
- Patients who have a clinically suspected VTE and/or scheduled for CT scans for suspected VTE.
- Patients not willing to complete survey tools.
- Prior history of PE or DVT.
- Eastern Cooperative Oncology Group (ECOG)/Zubrod Performance Status score of 4.
- Patients currently on anticoagulation therapy (low molecular weight heparin, fondaparinux, dalteparin, warfarin or unfractionated heparin). Patients on heparin flushes for indwelling catheters will not be excluded.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
1187 Patients enrolled
Trial Details
Trial ID
NCT00925808
Start Date
June 1 2009
End Date
June 1 2021
Last Update
August 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030